HealthMyne received clearance from the U.S. Food and Drug Administration on its imaging informatics platform, the company announced recently.
“Having a strong diagnostic imaging platform cleared by the FDA is the first step in our vision of bringing imaging informatics to mainstream healthcare,” HealthMyne CEO Praveen Sinha said in a statement.
According to a release, the platform is designed to streamline clinical decision support and integrate with enterprise PACS and vendor-neutral archives using industry-standard formats.
One thought on “HealthMyne Platform Gets FDA Clearance”